Skip to main content
SpringerLink
Log in

Functional Analyses Help to Assess the Pathogenicity of MMR Gene Variants of Uncertain Significance

  • Chapter
  • First Online:
DNA Alterations in Lynch Syndrome

  • 858 Accesses

Abstract

Knowing that inherited defects in mismatch repair (MMR) genes predispose to Lynch syndrome (LS), the identification of these mutations in suspected LS families is of prime importance. However, a major problem in the diagnosis and management of LS is the frequent occurrence of variants of uncertain significance (VUS) in the MMR genes. The consequence of a non-truncating mutation can vary from none to complete dysfunction of the protein. Thus, functional assessment by investigating how a non-truncating mutation affects the quantity and biochemical behaviour of the protein variant as compared to the wild-type protein has been shown to be an efficient manner to determine the pathogenicity of MMR gene variations. Furthermore, a stepwise assessment model emphasizing the use of family history and tumour pathological data to guide during the assessment process has been applied. Overall, the model utilizes data from incompletely validated assays supplemented with data derived from other sources such as from in silico analyses to classify VUS for clinical purposes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Järvinen HJ, Aarnio M (2000) Surveillance on mutation carriers of DNA mismatch repair genes. Ann Chir Gynaecol 89:207–210

    PubMed  Google Scholar 

  2. Mecklin JP, Aarnio M, Läärä E, Kairaluoma MV, Pylvänäinen K, Peltomäki P, Aaltonen LA, Järvinen HJ (2007) Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133:1093–1098. doi:10.1053/j.gastro.2007-08-019

    Article  PubMed  Google Scholar 

  3. Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin JP (2009) Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negativefamily members. J Clin Oncol 27:4793–4797. doi:10.1200/JCO.2009.23.7784

    Article  PubMed  Google Scholar 

  4. Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS, IARC Unclassified Genetic Variants Working Group (2008) Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29:1265–1272. doi:10.1002/humu.20897

    Article  PubMed  Google Scholar 

  5. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424–425

    Article  PubMed  CAS  Google Scholar 

  6. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453–1456

    Article  PubMed  CAS  Google Scholar 

  7. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268. doi:10.1093/jnci/djh034

    Article  PubMed  CAS  Google Scholar 

  8. Genuardi M, Carrara S, Anti M, Ponz de Leòn M, Viel A (1999) Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2. Eur J Hum Genet 7:778–782. doi:10.1038/sj.ejhg.5200363

    Article  PubMed  CAS  Google Scholar 

  9. Barnetson RA, Cartwright N, van Vliet A, Haq N, Drew K, Farrington S, Williams N, Warner J, Campbell H, Porteous ME, Dunlop MG (2008) Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer. Hum Mutat 29:367–374. doi:10.1002/humu.20635

    Article  PubMed  CAS  Google Scholar 

  10. Shimodaira H, Filosi N, Shibata H, Suzuki T, Radice P, Kanamaru R, Friend SH, Kolodner RD, Ishioka C (1998) Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet 19:384–389. doi:10.1038/1277

    Article  PubMed  CAS  Google Scholar 

  11. Clark AB, Cook ME, Tran HT, Gordenin DA, Resnick MA, Kunkel TA (1999) Functional analysis of human MutSalpha and MutSbeta complexes in yeast. Nucleic Acids Res 27:736–742. doi:10.1093/nar/27.3.736

    Article  PubMed  CAS  Google Scholar 

  12. Drotschmann K, Clark AB, Tran HT, Resnick MA, Gordenin DA, Kunkel TA (1999) Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene. Proc Natl Acad Sci U S A 96:2970–2975. doi:10.1073/pnas.96.6.2970

    Article  PubMed  CAS  Google Scholar 

  13. Shcherbakova PV, Kunkel TA (1999) Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol 19:3177–3183

    PubMed  CAS  Google Scholar 

  14. Vogelsang M, Comino A, Zupanec N, Hudler P, Komel R (2009) Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast. BMC Cancer 9:382. doi:10.1186/1471-2407-9-382

    Article  PubMed  Google Scholar 

  15. Ellison AR, Lofting J, Bitter GA (2001) Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 10:1889–1900. doi:10.1093/hmg/10.18.1889

    Article  PubMed  CAS  Google Scholar 

  16. Ellison AR, Lofting J, Bitter GA (2004) Human Mutl homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res 32:5321–5338. doi:10.1093/nar/gkh855

    Article  PubMed  CAS  Google Scholar 

  17. Nyström-Lahti M, Perrera C, Räschle M, Panyushkina-Seiler E, Marra G, Curci A, Quaresima B, Costanzo F, D’Urso M, Venuta S, Jiricny J (2002) Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 33:160–167. doi:10.1002/gcc.1225

    Article  PubMed  Google Scholar 

  18. Trojan J, Zeuzem S, Randolph A, Hemmerle C, Brieger A, Raedle J, Plotz G, Jiricny J, Marra G (2002) Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology 122:211–219. doi:10.1053/gast.2002.30296

    Article  PubMed  CAS  Google Scholar 

  19. Lahue RS, Au KG, Modrich P (1989) DNA mismatch correction in a defined system. Science 245:160–164. doi:10.1126/science.2665076

    Article  PubMed  CAS  Google Scholar 

  20. Drost M, Zonneveld JB, van Dijk L, Morreau H, Tops CM, Vasen HF, Wijnen JT, de Wind N (2010) A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1. Hum Mutat 31:247–253. doi:10.1002/humu.21180

    Article  PubMed  CAS  Google Scholar 

  21. Thomas DC, Roberts JD, Kunkel TA (1991) Heteroduplex repair in extracts of human HeLa cells. J Biol Chem 266:3744–3751

    PubMed  CAS  Google Scholar 

  22. Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lönnqvist KE, Holinski-Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes AM, Peltomäki P, Kohonen-Ccorish M, Mangold E, Macrae F, Greenblatt M, de la Chapelle A, Nyström M (2005) Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 129:537–549. doi:10.1016/j.gastro.2005.06.005

    PubMed  CAS  Google Scholar 

  23. Korhonen MK, Vuorenmaa E, Nystrom M (2008) The first functional study of MLH3 mutations found in cancer patients. Genes Chromosomes Cancer 47:803–809. doi:10.1002/gcc.20581

    Article  PubMed  CAS  Google Scholar 

  24. Drost M, Zonneveld JB, van Hees S, Rasmussen LJ, Hofstra RM, de Wind N (2012) A rapid and cell-free assay to test the activity of Lynch syndrome-associated MSH2 and MSH6 missense variants. Hum Mutat 33:488–494. doi:10.1002/humu.22000

    Article  PubMed  CAS  Google Scholar 

  25. Kantelinen J, Kansikas M, Candelin S, Hampel H, Smith B, Holm L, Kariola R, Nyström M (2012) Mismatch repair analysis of inherited MSH2 and/or MSH6 variation pairs found in cancer patients. Hum Mutat 33:1294–1301. doi:10.1002/humu.22119

    Article  PubMed  CAS  Google Scholar 

  26. Kantelinen J, Kansikas M, Korhonen MK, Ollila S, Heinimann K, Kariola R, Nyström M (2010) MutSbeta exceeds MutSalpha in dinucleotide loop repair. Br J Cancer 102:1068–1073. doi:10.1038/sj.bjc.6605531

    Article  PubMed  CAS  Google Scholar 

  27. Takahashi M, Shimodaira H, Andreutti-Zaugg C, Iggo R, Kolodner RD, Ishioka C (2007) Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 67:4595–4604. doi:10.1158/0008-5472

    Article  PubMed  CAS  Google Scholar 

  28. Mastrocola AS, Heinen CD (2010) Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo. Hum Mutat 31:1699–1708. doi:10.1002/humu.21333

    Article  Google Scholar 

  29. Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-­Corish M, Gerdes AM, Peltomäki P, Mangold E, de la Chapelle A, Greenblatt M, Nyström M (2006) Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408–1417. doi:10.1053/j.gastro.2006.08.044

    Article  PubMed  CAS  Google Scholar 

  30. Gammie AE, Erdeniz N, Beaver J, Devlin B, Nanji A, Rose MD (2007) Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Genetics 177:707–721. doi:10.1534/genetics.107.071084

    Article  PubMed  CAS  Google Scholar 

  31. Guerrette S, Acharya S, Fishel R (1999) The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 274:6336–6341. doi:10.1074/jbc.274.10.6336

    Article  PubMed  CAS  Google Scholar 

  32. Kondo E, Suzuki H, Horii A, Fukushige S (2003) A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res 63:3302–3308

    PubMed  CAS  Google Scholar 

  33. Jäger AC, Rasmussen M, Bisgaard HC, Singh KK, Nielsen FC, Rasmussen LJ (2001) HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLalpha and hMLH1-hEXO1 complexes. Oncogene 20:3590–3595. doi:10.1038/sj.onc.1204467

    Article  PubMed  Google Scholar 

  34. Andersen SD, Liberti SE, Lützen A, Drost M, Bernstein I, Nilbert M, Dominguez M, Nyström M, Hansen TV, Christoffersen JW, Jäger AC, de Wind N, Nielsen FC, Tørring PM, Rasmussen LJ (2012) Functional characterization of MLH1 missense variants identified in Lynch syndrome patients. Hum Mutat 33:1647–1655. doi:10.1002/humu.22153

    Article  PubMed  CAS  Google Scholar 

  35. Guerrette S, Wilson T, Gradia S, Fishel R (1998) Interactions of Human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol Cell Biol 18:6616–6623

    PubMed  CAS  Google Scholar 

  36. Kariola R, Raevaara TE, Lönnqvist KE, Nyström-Lahti M (2002) Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 11:1303–1310. doi:10.1093/hmg/11.11.1303

    Article  PubMed  CAS  Google Scholar 

  37. Kariola R, Hampel H, Frankel WL, Raevaara TE, de la Chapelle A, Nyström-Lahti M (2004) MSH6 missense mutations are often associated with no or low cancer susceptibility. Br J Cancer 91:1287–1292. doi:10.1038/sj.bjc.6602129

    Article  PubMed  CAS  Google Scholar 

  38. James P, Halladay J, Craig EA (1996) Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144:1425–1436

    PubMed  CAS  Google Scholar 

  39. Korhonen MK, Raevaara TE, Lohi H, Nystrom M (2007) Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC. Oncol Rep 17:351–354

    PubMed  CAS  Google Scholar 

  40. Lützen A, de Wind N, Georgijevic D, Nielsen FC, Rasmussen LJ (2008) Functional analysis of HNPCC-related missense mutations in MSH2. Mutat Res 645:44–55. doi:10.1016/j.mrfmmm.2008.08.015

    Article  PubMed  Google Scholar 

  41. Heinen CD, Wilson T, Mazurek A, Berardini M, Butz C, Fishel R (2002) HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell 1:469–478. doi:10.1016/j.bbr.2011.03.031

    Article  PubMed  CAS  Google Scholar 

  42. Ollila S, Dermadi Bebek D, Jiricny J, Nyström M (2008) Mechanisms of pathogenicity in human MSH2 missense mutants. Hum Mutat 29:1355–1363. doi:10.1002/humu.20893

    Article  PubMed  CAS  Google Scholar 

  43. Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282–1291. doi:10.1002/humu.20880

    Article  PubMed  CAS  Google Scholar 

  44. Tavtigian SJ, Greenblatt MS, Lesueur F, Byrnes GB (2008) In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat 29:1327–1336. doi:10.1002/humu.20892

    Article  PubMed  CAS  Google Scholar 

  45. Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins MA, Brown MA, Tavtigian SV, Goldgar DE, Young JP, Spurdle AB (2009) Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Hum Mutat 30:757–770. doi:10.1002/humu.20936

    Article  PubMed  CAS  Google Scholar 

  46. Spurdle AB (2010) Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models. Curr Opin Genet Dev 20:315–323. doi:10.1016/j.gde.2010.03.009

    Article  PubMed  CAS  Google Scholar 

  47. Deschênes SM, Tomer G, Nguyen M, Erdeniz N, Juba NC, Sepúlveda N, Pisani JE, Liskay RM (2007) The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair. Cancer Lett 249:148–156. doi:10.1016/j.canlet.2006.08.008

    Article  PubMed  Google Scholar 

  48. Kansikas M, Kariola R, Nyström M (2011) Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants. Hum Mutat 32:107–115. doi:10.1002/humu.21409

    Article  PubMed  CAS  Google Scholar 

  49. Couch FJ, Rasmussen LJ, Hofstra R, Monteiro ANA, Greenblatt MS, de Wind N, IARC Unclassified Variants Working Group (2008) Assessment of functional effects of unclassified genetic variants. Hum Mutat 29:1314–1326. doi:10.1002/humu.20899

    Article  PubMed  CAS  Google Scholar 

  50. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851–1860. doi:10.1056/NEJMoa043146

    Article  PubMed  CAS  Google Scholar 

  51. Mangold E, Pagenstecher C, Friedl W, Fischer HP, Merkelbach-Bruse S, Ohlendorf M, Friedrichs N, Aretz S, Buettner R, Propping P, Mathiak M (2005) Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol 207:385–395. doi:10.1002/path.1858

    Article  PubMed  CAS  Google Scholar 

  52. Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR (2000) Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:18424–18431. doi:10.1074/jbc.M001140200

    Article  PubMed  CAS  Google Scholar 

  53. Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 41:112–117. doi:10.1038/ng.283

    Article  PubMed  CAS  Google Scholar 

  54. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808–811

    PubMed  CAS  Google Scholar 

  55. Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espín E, Armengol M, Sijmons RH, Kleibeuker JH, Seruca R, Aaltonen LA, Imai K, Yamamoto H, Schwartz S Jr, Hofstra RM (2005) BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 24:3995–3998

    Article  PubMed  CAS  Google Scholar 

  56. Hendriks YMC, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Winjen JT, Bröcker-Vriends AHJT, Vasen H (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127:17–25. doi:10.1016/j.bbr.2011.03.031

    Article  PubMed  CAS  Google Scholar 

  57. Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nyström M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS (2007) Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28:683–693. doi:10.1002/humu.20492

    Article  PubMed  CAS  Google Scholar 

  58. Ali H, Olatubosun A, Vihinen M (2012) Classification of mismatch repair gene missense variants with PON-MMR. Hum Mutat 33:642–650. doi:10.1002/humu.22038

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biosciences, Genetics, University of Helsinki, Helsinki, Finland

    Minna Nyström & Minttu Kansikas

Authors
  1. Minna Nyström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Minttu Kansikas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minna Nyström .

Editor information

Editors and Affiliations

  1. , Laboratory for Molecular Biology, National Institute of Chemistry, Hajdrihova 19, Ljubljana, SI-1001, Slovenia

    Matjaž Vogelsang

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Nyström, M., Kansikas, M. (2013). Functional Analyses Help to Assess the Pathogenicity of MMR Gene Variants of Uncertain Significance. In: Vogelsang, M. (eds) DNA Alterations in Lynch Syndrome. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6597-9_5

Download citation

Publish with us

Policies and ethics

Search

Navigation